See up to 3 months of CDNA. The 7-day demo opens the 1M and 3M ranges and puts CDNA on your watchlist.
Start 7-day demoLatest CDNA insider trades
George Bickerstaff - DirectorOpen-market sale$926K
Christine Cournoyer - DirectorOpen-market sale$751K
About CareDx, Inc. (CDNA)
CareDx, Inc. files with the SEC under CIK 0001217234 and is classified as medical laboratories. We track it alongside the rest of the Health Care sector.
CDNA Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 9 | 230,167 | $9.40M |
| Grant or award | 1 | 588 | |
| Option exercise | 8 | 293,558 | |
CDNA insider transactions (Form 4)
43101 Form 4 filings on record, the earliest from Oct 8, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| George Bickerstaff | Option exercise | Common Stock | 29,136 | $7.96 | $232K | |
| George Bickerstaff | Option exercise | Stock Option (right to buy) | 29,136 | $0.00 | - | |
| Nathan Smith - Officer | Grant or award | Common Stock | 42,000 | $0.00 | - | |
 Jeffrey Adam Novack - Officer | Open-market sale | Common Stock | 2,688 | $12.79 | $34K | |
| Jeffrey Adam Novack - Officer | Tax withholding / forfeiture | Common Stock | 2,873 | $12.22 | $35K | |
 Abhishek Jain - Officer | Tax withholding / forfeiture | Common Stock | 7,687 | $12.22 | $94K | |
 Michael Goldberg | Grant or award | Common Stock | 1,218 | $0.00 | - | |
| Jeffrey Adam Novack - Officer | Tax withholding / forfeiture | Common Stock | 276 | $18.45 | $5K | |
| Peter Maag | Open-market sale | Common Stock | 10,000 | $18.58 | $186K | |
| Hannah Valantine | Open-market sale | Common Stock | 10,570 | $19.16 | $203K | |
| Peter Maag | Open-market sale | Common Stock | 10,000 | $19.24 | $192K | |
| Michael Goldberg - Director | Grant or award | Common Stock | 12,103 | $0.00 | - | |
| Fred E. Cohen | Grant or award | Common Stock | 12,103 | $0.00 | - | |
| Peter Maag | Grant or award | Common Stock | 12,103 | $0.00 | - | |
| Richard Bryan Riggsbee | Grant or award | Common Stock | 12,103 | $0.00 | - | |
| Arthur A. Torres | Grant or award | Common Stock | 12,103 | $0.00 | - | |
| George Bickerstaff | Grant or award | Common Stock | 12,103 | $0.00 | - | |
| Hannah Valantine | Grant or award | Common Stock | 12,103 | $0.00 | - | |
| Christine Cournoyer | Grant or award | Common Stock | 12,103 | $0.00 | - | |
| William A. Hagstrom | Option exercise | Common Stock | 15,000 | $14.74 | $221K | |
| William A. Hagstrom | Option exercise | Common Stock | 4,391 | $7.96 | $35K | |
| William A. Hagstrom | Open-market sale | Common Stock | 19,391 | $19.90 | $386K | |
| William A. Hagstrom | Option exercise | Stock Option (right to buy) | 15,000 | $0.00 | - | |
| William A. Hagstrom | Option exercise | Stock Option (right to buy) | 4,391 | $0.00 | - | |
| Jeffrey Adam Novack - Officer | Tax withholding / forfeiture | Common Stock | 2,583 | $19.52 | $50K | |
| William A. Hagstrom | Option exercise | Common Stock | 4,745 | $4.95 | $23K | |
| William A. Hagstrom | Option exercise | Common Stock | 24,745 | $7.96 | $197K | |
| William A. Hagstrom | Option exercise | Common Stock | 510 | $5.85 | $3K | |
| William A. Hagstrom | Open-market sale | Common Stock | 30,000 | $17.45 | $523K | |
| William A. Hagstrom | Option exercise | Stock Option (right to buy) | 4,745 | $0.00 | - | |
| William A. Hagstrom | Option exercise | Stock Option (right to buy) | 24,745 | $0.00 | - | |
| William A. Hagstrom | Option exercise | Stock Option (right to buy) | 510 | $0.00 | - | |
| Abhishek Jain - Officer | Tax withholding / forfeiture | Common Stock | 1,982 | $17.63 | $35K | |
| Christine Cournoyer - Director | Option exercise | Common Stock | 29,136 | $7.96 | $232K | |
| Christine Cournoyer - Director | Open-market sale | Common Stock | 29,136 | $15.96 | $465K | |
| Christine Cournoyer - Director | Option exercise | Stock Option (right to buy) | 29,136 | $0.00 | - | |
| Christine Cournoyer - Director | Open-market sale | Common Stock | 16,700 | $14.13 | $236K | |
| Jeffrey Adam Novack - Officer | Open-market sale | Common Stock | 2,688 | $14.70 | $40K | |
| Jeffrey Adam Novack - Officer | Tax withholding / forfeiture | Common Stock | 2,873 | $15.07 | $43K | |
| Abhishek Jain - Officer | Tax withholding / forfeiture | Common Stock | 7,686 | $15.07 | $116K | |
| Peter Maag | Open-market sale | Common Stock | 13,281 | $17.23 | $229K | |
| Abhishek Jain - Officer | Tax withholding / forfeiture | Common Stock | 338 | $16.94 | $6K | |
| John Walter Hanna Jr. - Officer | Tax withholding / forfeiture | Common Stock | 61,469 | $19.16 | $1.18M |
See every CDNA filing on record
These pages show the latest 90 of 101 Form 4 filings on record. The 7-day demo shows all 101, and sign-up brings you back to this table.
Recent CDNA Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| PETER MAAG | Director | 9,122 | $423K | View on EDGAR | |
| PETER MAAG | Director | 7,000 | $317K |
CDNA insider trading FAQ
What is the latest insider trade for CDNA?
CareDx, Inc. (CDNA) had 14 insider filings in the last 90 days, with the most recent on 2026-10-05. The full record for CDNA runs to 101 Form 4 filings, the earliest from 2024-10-08. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CDNA stock?
No insider purchases of CDNA were filed in the last 90 days.
How many insiders are selling CDNA stock?
9 insider sales of CDNA were filed in the last 90 days, totaling $9.40M.
Where can I see CDNA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CDNA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jeffrey Adam Novack view on EDGAR
- - John Walter Hanna Jr. view on EDGAR
- - Keith Kennedy view on EDGAR
- - Jessica Meng view on EDGAR
- - Michael Goldberg view on EDGAR
- - Keith Kennedy view on EDGAR
- - Jessica Meng view on EDGAR
- - George Bickerstaff view on EDGAR
- - Christine Cournoyer view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where CDNA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CDNA with a 7-day demo
- CDNA on your watchlist
- Every CDNA Form 4 filing on record
- Up to 3 months of CDNA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
